Correlation Between Shenzhen Mindray and Shenzhen Hifuture

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shenzhen Mindray and Shenzhen Hifuture at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Mindray and Shenzhen Hifuture into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shenzhen Mindray Bio Medical and Shenzhen Hifuture Electric, you can compare the effects of market volatilities on Shenzhen Mindray and Shenzhen Hifuture and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Mindray with a short position of Shenzhen Hifuture. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Mindray and Shenzhen Hifuture.

Diversification Opportunities for Shenzhen Mindray and Shenzhen Hifuture

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Shenzhen and Shenzhen is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Mindray Bio Medical and Shenzhen Hifuture Electric in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Hifuture and Shenzhen Mindray is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Mindray Bio Medical are associated (or correlated) with Shenzhen Hifuture. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Hifuture has no effect on the direction of Shenzhen Mindray i.e., Shenzhen Mindray and Shenzhen Hifuture go up and down completely randomly.

Pair Corralation between Shenzhen Mindray and Shenzhen Hifuture

Assuming the 90 days trading horizon Shenzhen Mindray Bio Medical is expected to under-perform the Shenzhen Hifuture. But the stock apears to be less risky and, when comparing its historical volatility, Shenzhen Mindray Bio Medical is 1.45 times less risky than Shenzhen Hifuture. The stock trades about -0.03 of its potential returns per unit of risk. The Shenzhen Hifuture Electric is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest  229.00  in Shenzhen Hifuture Electric on September 2, 2024 and sell it today you would earn a total of  53.00  from holding Shenzhen Hifuture Electric or generate 23.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Shenzhen Mindray Bio Medical  vs.  Shenzhen Hifuture Electric

 Performance 
       Timeline  
Shenzhen Mindray Bio 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Mindray Bio Medical are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Mindray may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Shenzhen Hifuture 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Hifuture Electric are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Hifuture may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Shenzhen Mindray and Shenzhen Hifuture Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shenzhen Mindray and Shenzhen Hifuture

The main advantage of trading using opposite Shenzhen Mindray and Shenzhen Hifuture positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Mindray position performs unexpectedly, Shenzhen Hifuture can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Hifuture will offset losses from the drop in Shenzhen Hifuture's long position.
The idea behind Shenzhen Mindray Bio Medical and Shenzhen Hifuture Electric pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation